相关实验视频
Updated: May 22, 2025

11:42
Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
Published on: April 7, 2017
9.3K
在骨髓肉瘤进展中的上皮-半机关过渡的作用:从生物学到治疗
Andrei-Valentin Patrașcu1, Elena Țarcă2, Ludmila Lozneanu3
1Department of Morphofunctional Sciences I-Pathology, Faculty of Medicine, "Grigore T. Popa" University of Medicine and Pharmacy, 700115 Iasi, Romania.
Diagnostics (Basel, Switzerland)
|March 13, 2025
概括
皮质-介质细胞过渡 (EMT) 驱动骨髓瘤的进展,入侵和儿童和年轻人的治疗耐药性. 准EMT为这种常见的骨癌提供了新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 骨髓瘤 (OS) 是儿科和年轻成年人群中最常见的原发性恶性骨瘤.
- 皮质 - 介质细胞过渡 (EMT) 在癌症中得到了很好的研究,但在像OS这样的介质细胞瘤中不太被探索.
- EMT越来越多地与OS的进展有关,有助于侵袭,转移和化学抵抗.
研究的目的:
- 提供对驱动骨髓瘤EMT的分子机制的全面审查.
- 要突出信号通路,转录因子和微RNA在OS相关EMT中的作用.
- 讨论EMT在OS预后和治疗耐药性的临床影响.
主要方法:
- 关于骨髓瘤EMT现有文献的叙述性综述.
- 对参与EMT的分子通路 (例如TGF-β) 和转录因子 (Snail,Twist,Zeb) 的分析.
- 检查微RNAs在调节EMT过程中的作用.
主要成果:
- EMT是骨髓瘤入侵,转移和抗化疗的关键驱动因素.
- 特定的信号通路和转录因子是OS中EMT的关键调节者.
- 在骨髓瘤患者中,EMT与不良预后和治疗挑战有很强的相关性.
结论:
- 准EMT途径为骨髓瘤提供了一个有前途的治疗策略.
- 了解EMT机制可以导致新的治疗方法,包括EMT抑制剂和组合疗法.
- 在改善骨髓瘤的结果方面,EMT是关键的目标.
相关概念视频
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
Mesenchymal Stem Cells
4.6K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.6K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
The Tumor Microenvironment
6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K

